To study the safety and efficacy of adult stem cell therapy in treating end stage lung diseases
Phase 1
- Conditions
- Health Condition 1: null- COPD and IPF
- Registration Number
- CTRI/2015/02/005569
- Lead Sponsor
- Global Hospiatls
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
Ineffective clinical treatment,Limited physical activity,cessation of smoking for >6 months
Exclusion Criteria
Patient on ventilator,Diagnosis of malignancy,H/o severe CAD,Significant liver kidney disease,psychiatric illness,Active smoker,Consent not given,Pregnancy,Diagnosed case of HIV,active TB,Secondary infections
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety without any adverse event [AE] in the studyTimepoint: 24 months
- Secondary Outcome Measures
Name Time Method Pulmonary function tests,Exercise capability and Quality of lifeTimepoint: 2 years